Canopy Growth (CGC) Free Cash Flow (QoQ) (2019 - 2024)
Canopy Growth (CGC) Free Cash Flow (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Canopy Growth | 270.68 Mn | 4.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 51.24% |
| Sep 30, 2024 | -1.60% |
| Jun 30, 2024 | -145.99% |
| Mar 31, 2024 | 31.98% |
| Dec 31, 2023 | 73.21% |
| Sep 30, 2023 | -12.82% |
| Jun 30, 2023 | -632.38% |
| Mar 31, 2023 | 110.37% |
| Dec 31, 2022 | -128.49% |
| Sep 30, 2022 | 43.02% |
| Jun 30, 2022 | -421.17% |
| Mar 31, 2022 | 83.91% |
| Dec 31, 2021 | -65.89% |
| Sep 30, 2021 | 46.81% |
| Jun 30, 2021 | 16.01% |
| Mar 31, 2021 | -642.45% |
| Dec 31, 2020 | 83.01% |
| Sep 30, 2020 | -10.00% |
| Jun 30, 2020 | 79.96% |
| Mar 31, 2020 | -691.38% |